Yoshinao Wada


Affiliation: Osaka Medical Center for Cancer and Cardiovascular Diseases
Country: Japan


  1. Wada Y. Glycan profiling: label-free analysis of glycoproteins. Methods Mol Biol. 2013;951:245-53 pubmed publisher
    ..Glycopeptide is a suitable analyte for this label-free approach. ..
  2. Tanaka K, Takenaka S, Tsuyama S, Wada Y. Determination of unique amino acid substitutions in protein variants by peptide mass mapping with FT-ICR MS. J Am Soc Mass Spectrom. 2006;17:508-513 pubmed publisher
    ..Therefore, FTICR MS is capable of identifying all 53 types of substitutions, each of which is associated with a unique mass difference, except for the Leu and Ile isomers. ..
  3. Wada Y, Dell A, Haslam S, Tissot B, Canis K, Azadi P, et al. Comparison of methods for profiling O-glycosylation: Human Proteome Organisation Human Disease Glycomics/Proteome Initiative multi-institutional study of IgA1. Mol Cell Proteomics. 2010;9:719-27 pubmed publisher
    ..In addition, mass spectrometric methodologies to analyze O-glycopeptides were also successful. ..
  4. Wada Y, Tajiri M, Ohshima S. Quantitation of saccharide compositions of O-glycans by mass spectrometry of glycopeptides and its application to rheumatoid arthritis. J Proteome Res. 2010;9:1367-73 pubmed publisher
  5. Fujihara A, Inoue H, Sogi M, Tajiri M, Wada Y. Chiral and Molecular Recognition through Protonation between Aromatic Amino Acids and Tripeptides Probed by Collision-Activated Dissociation in the Gas Phase. Molecules. 2018;23: pubmed publisher
    ..The amino-acid sequences of the tripeptides required for the recognition of aromatic amino acids were determined by analyses of the CAD spectra. ..
  6. Wada Y. Mass spectrometry of transferrin and apolipoprotein C-III for diagnosis and screening of congenital disorder of glycosylation. Glycoconj J. 2016;33:297-307 pubmed publisher
    ..In this technological review, the principle and pitfalls of MS for CDG are discussed and mass spectra of various types of CDG are presented. ..